title: The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection.
abstract: Lyme borreliosis (LB) is the most prevalent arthropod-borne infectious disease in North America and many countries of the temperate Northern Hemisphere. It is associated with local and systemic manifestations and has persistent post-treatment health complications in some individuals. Innate and acquired immunity-related inflammation is likely to play a critical role in both host defense against Borrelia burgdorferi and disease severity. Large-scale analytical approaches to quantify gene expression (transcriptomics), proteins (proteomics) and metabolites (metabolomics) in LB have recently emerged with a potential to advance the development of disease biomarkers in early, disseminated and posttreatment disease stages. These technologies may permit defining the disease stage and facilitate its early detection to improve diagnosis. They will also likely allow elucidating the underlying molecular pathways to aid in identifying molecular targets for therapy. This article reviews the findings within the field of omics relevant to LB and its prospective utility in developing an array of biomarkers that can be employed in LB diagnosis and detection particularly at the early disease stages.
authors.affiliation: Public Health Risk Sciences Division, Public Health Agency of Canada, 180 Queen Street West, Toronto, ON, Canada. alaa.badawi@phac-aspc.gc.ca.|Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, FitzGerald Building, 150 College Street, Toronto, ON, Canada. alaa.badawi@phac-aspc.gc.ca.
authors.forename: Alaa
authors.initials: A
authors.lastname: Badawi
keywords: Biomarkers; Diagnosis; Inflammation; Innate immunity; Lyme disease; Omics